The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Fatty Acids - Induced Lipotoxicity and Inflammation
Abstract
Fatty acids are known to serve as energetic substrates, key components of membrane lipids, and as substrates for the synthesis of signaling molecules and complex lipids. They are also known to be ligands either of membrane receptors involved in cell signaling or of nuclear receptors mediating gene regulation. Accumulation of fatty acids due to altered metabolism and/or unbalanced diet has been described to be toxic for several tissues, especially liver. In numerous cell types, cell death, cytokine secretion and activation of inflammatory processes appear to be a consequence of fatty acid accumulation. This review presents the different classes of fatty acids known to trigger toxic effects and inflammation, the cellular and subcellular targets of these fatty acids in the context of non-alcoholic fatty liver disease (NAFLD), and the mechanisms by which these effects are mediated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides them, cholesterol oxide derivatives and other long chain derivatives of fatty acids including prostaglandins, leukotrienes and neuroprotectins are present [63, 64].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [64]
Citations
Cites
1 retracted
Comparative toxicity of oleic and linoleic acid on human lymphocytes
Cury‐Boaventura, M. F., Gorjão, R., de Lima, T. M., Newsholme, P., & Curi, R. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.038 · Cited by 137
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Cited by
Sorted by citations
Items 101–111 of 111
Cao, M., Li, C., Xu, X., Zhu, C., Xu, H., Sun, J., Shang, J., Zhou, S., Zhou, S., & Zhu, X. (2026) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2026.104562 · Cited by 1
Hayashi, S., Ogawa, Y., Wakabayashi, N., Tokuyama, K., Oku, M., Yamamoto, T., Kato, S., Nusrat, A., & Kadowaki, M. (2026) · The FASEB Journal · doi:10.1096/fj.202504287r · Cited by 1
Current and future strategies aiming at reducing catecholamine exposure in septic shock
Dubech, A., Picod, A., Pierre, A., Préau, S., Favory, R., & Garcia, B. (2026) · Critical Care · doi:10.1186/s13054-026-06109-3 · Cited by 1
Bezine, M. (2017) · theses.fr (ABES) · doi:10.70675/a634c389z7b07z4830zb56dzbf7b53a56944 · Cited by 1
Plant life-associated natural products: Algae and mushrooms
Noguera, N. H., & Lima, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99111-7.00003-9
Kharrassi, Y. E. (2015) · theses.fr (ABES) · doi:10.70675/b4faa240z73eez450bz8332z946a77b3f157
Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals
Jiménez-Martínez, M., de Jong, T. A., Houtman, M., Semmelink, J. F., Zelcer, N., van de Sande, M. G. H., Dankers, W., & van Baarsen, L. G. M. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.05.005
张, 晓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1672703
Moreto, F. (2013) · Americanae (AECID Library)
Metadata
- Authors
- Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G.
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-10-01
- Volume
- 13
- Issue
- 10
- Pages
- 1358-1370
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2028509006
- Cited by
- 111
- References
- 175
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 4 · 2023: 5 · 2022: 12 · 2021: 7 · 2020: 13 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 1
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- fatty acids, lipotoxicity, inflammation, non-alcoholic fatty liver disease, fatty acid accumulation, cell death, cytokine production, nuclear receptors, cell surface receptors, hepatotoxicity, lipid metabolism
- MeSH terms
- Animals, Fatty Acids, Fatty Liver, Humans, Inflammation, Oxidative Stress, Hepatocytes, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
